DANAHER CORPORATION

Lobbying for DANAHER CORPORATION · health care products developer and manufacturer

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $160,000.00 expenses · posted Jan 19, 2026

Lobbying activity 2

Health Issues

Issues related to biotechnology, cell and gene therapy

Tariff (miscellaneous tariff bills)

General issues related to tariffs

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.